{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:06:24Z","timestamp":1792710384544,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12891-015-0773-1","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T11:57:44Z","timestamp":1446638264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1186","volume":"16","author":[{"given":"Hideki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Horai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsufumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"773_CR1","first-page":"182","volume":"47","author":"T Nakamura","year":"2009","unstructured":"Nakamura T. HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Folia Neuropathol. 2009;47:182\u201394.","journal-title":"Folia Neuropathol"},{"key":"773_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beha.2013.04.001","volume":"26","author":"K Tsukasaki","year":"2013","unstructured":"Tsukasaki K, Tobinai K. Biology and treatment of HTLV-1 associated T-cell lymphomas. Best Pract Res Clin Haematol. 2013;26:3\u201314.","journal-title":"Best Pract Res Clin Haematol"},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.trsl.2006.07.003","volume":"148","author":"H Nakamura","year":"2006","unstructured":"Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sj\u00f6gren's syndrome. Transl Res. 2006;148:281\u20138.","journal-title":"Transl Res"},{"issue":"9482","key":"773_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sj\u00f6gren\u2019s syndrome. Lancet. 2005;366(9482):321\u201331.","journal-title":"Lancet"},{"key":"773_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/1744666X.2014.901888","volume":"10","author":"C Miceli-Richard","year":"2014","unstructured":"Miceli-Richard C, Criswell LA. Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sj\u00f6gren\u2019s syndrome. Expert Rev Clin Immunol. 2014;10:437\u201344.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8930","key":"773_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","volume":"344","author":"K Terada","year":"1994","unstructured":"Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sj\u00f6gren\u2019s syndrome. Lancet. 1994;344(8930):1116\u20139.","journal-title":"Lancet"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1086\/314588","volume":"179","author":"F Tangy","year":"1999","unstructured":"Tangy F, Ossondo M, Vernant JC, Smadja D, Bl\u00e9try O, Baglin AC, et al. Human T cell leukemia virus type I expression in salivary glands of infected patients. J Infect Dis. 1999;179:497\u2013502.","journal-title":"J Infect Dis"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.1780370415","volume":"37","author":"T Sumida","year":"1994","unstructured":"Sumida T, Yonaha F, Maeda T, Kita Y, Iwamoto I, Koike T, et al. Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1994;37:545\u201350.","journal-title":"Arthritis Rheum"},{"key":"773_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1365-2249.1992.tb06875.x","volume":"89","author":"WG Shattles","year":"1992","unstructured":"Shattles WG, Brookes SM, Venables PJ, Clark DA, Maini RN. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol. 1992;89:46\u201351.","journal-title":"Clin Exp Immunol"},{"key":"773_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/ard.56.3.167","volume":"56","author":"H Nakamura","year":"1997","unstructured":"Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, et al. High prevalence of Sj\u00f6gren\u2019s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis. 1997;56:167\u201372.","journal-title":"Ann Rheum Dis"},{"key":"773_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mlc.2000.103429","volume":"135","author":"H Nakamura","year":"2000","unstructured":"Nakamura H, Kawakami A, Tominaga M, Hida A, Yamasaki S, Migita K, et al. Relationship between Sj\u00f6gren\u2019s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med. 2000;135:139\u201344.","journal-title":"J Lab Clin Med"},{"key":"773_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome: results of a prospective concerted action supported by European Community. Arthritis Rheum. 1993;36:340\u20137.","journal-title":"Arthritis Rheum"},{"key":"773_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis."},{"key":"773_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64:475\u201387.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8488","key":"773_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031\u20132.","journal-title":"Lancet"},{"key":"773_CR16","first-page":"575","volume":"77","author":"P Rubin","year":"1957","unstructured":"Rubin P, Holt JF. Secretory sialography in disease of the major salivary gland. Am J Rentgenol. 1957;77:575\u201398.","journal-title":"Am J Rentgenol"},{"key":"773_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jcp.21.5.656","volume":"21","author":"DN Chisholm","year":"1968","unstructured":"Chisholm DN, Mason DK. Labial salivary gland biopsy in Sj\u00f6gren\u2019s disease. J Clin Pathol. 1968;21:656\u201360.","journal-title":"J Clin Pathol"},{"key":"773_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","volume":"37","author":"JS Greenspan","year":"1974","unstructured":"Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sj\u00f6gren\u2019s syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974;37:217\u201329.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"773_CR19","first-page":"915","volume":"23","author":"H Nakamura","year":"2005","unstructured":"Nakamura H, Kawakami A, Izumi M, Nakashima T, Takagi Y, Ida H, et al. Detection of the soluble form of Fas ligand (sFasL) and sFas in the saliva from patients with Sjogren\u2019s syndrome. Clin Exp Rheumatol. 2005;23:915.","journal-title":"Clin Exp Rheumatol."},{"issue":"6237","key":"773_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/341072a0","volume":"341","author":"JE Green","year":"1989","unstructured":"Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sj\u00f6gren\u2019s syndrome in HTLV-1 tax transgenic mice. Nature. 1989;341(6237):72\u20134.","journal-title":"Nature"},{"key":"773_CR21","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1136\/ard.2010.128736","volume":"69","author":"A Hida","year":"2010","unstructured":"Hida A, Imaizumi M, Sera N, Akahoshi M, Soda M, Maeda R, et al. Association of human T lymphotropic virus type I with Sjogren syndrome. Ann Rheum Dis. 2010;69:2056\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"116","key":"773_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"26","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;26(116):1211\u20139.","journal-title":"Blood"},{"key":"773_CR23","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557","volume":"92","author":"M Hisada","year":"1998","unstructured":"Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood. 1998;92:3557\u201361.","journal-title":"Blood"},{"key":"773_CR24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/rheumatology\/kep072","volume":"48","author":"H Nakamura","year":"2009","unstructured":"Nakamura H, Kawakami A, Hayashi T, Nakamura T, Iwamoto N, Yamasaki S, et al. Low prevalence of ectopic germinal centre formation in patients with HTLV-I-associated Sjogren\u2019s syndrome. Rheumatology (Oxford). 2009;48:854\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"6793","key":"773_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel KM, Ngo VN, Hyman PL, Luther SA, F\u00f6rster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406(6793):309\u201314.","journal-title":"Nature"},{"key":"773_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4049\/jimmunol.166.1.650","volume":"166","author":"K Shi","year":"2001","unstructured":"Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, et al. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol. 2001;166:650\u20135.","journal-title":"J Immunol"},{"key":"773_CR27","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/art.39009","volume":"67","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Takahashi Y, Yamamoto-Fukuda T, Horai Y, Nakashima Y, Arima K, et al. Direct infection of primary salivary gland epithelial cells by human T lymphptropic virus type I in patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2015;67:1096\u2013106.","journal-title":"Arthritis Rheumatol"},{"key":"773_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/acr.20173","volume":"62","author":"R Seror","year":"2010","unstructured":"Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Bootsma H, et al. Accurate detection of changes in disease activity in primary Sj\u00f6gren\u2019s syndrome by the European League Against Rheumatism Sj\u00f6gren\u2019s Syndrome Disease Activity Index. Arthritis Care Res (Hoboken). 2010;62:551\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"773_CR29","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG et al. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2014: Dec 5. [Epub ahead of print]."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0773-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-015-0773-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0773-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T19:01:13Z","timestamp":1599764473000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-015-0773-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1186\/s12891-015-0773-1","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"article-number":"335"}}